(S (SBAR (IN While) (S (NP (NP (DT a) (JJ large) (NN body)) (PP (IN of) (NP (NN research)))) (VP (VBZ has) (ADVP (RB formally)) (VP (VBN identified) (NP (NP (NN apolipoprotein) (NNP E)) (PRN (-LRB- -LRB-) (NP (NNP APOE)) (-RRB- -RRB-))) (PP (IN as) (NP (NP (DT a) (JJ major) (JJ genetic) (NN risk) (NN marker)) (PP (IN for) (NP (NNP Alzheimer) (NN disease))))))))) (, ,) (NP (VBG accumulating) (NN evidence)) (VP (VBZ supports) (NP (DT the) (NN notion) (SBAR (IN that) (S (NP (JJ other) (NN risk) (NNS markers)) (VP (MD may) (VP (VB exist))))))) (. .))
(S (NP (DT The) (JJ traditional) (JJ Alzheimer-specific) (NN signature) (NN analysis) (NNS methods)) (, ,) (ADVP (RB however)) (, ,) (VP (VBP have) (RB not) (VP (VBN been) (ADJP (JJ able) (S (VP (TO to) (VP (VB make) (NP (NP (JJ full) (NN use)) (PP (IN of) (NP (NP (JJ rich) (NN protein) (NN expression) (NNS data)) (, ,) (NP (NP (ADVP (RB especially)) (DT the) (NN interaction)) (PP (IN between) (NP (NNS attributes))))))))))))) (. .))
(S (NP (DT This) (NN paper)) (VP (VBZ develops) (NP (NP (DT a) (JJ novel) (NN feature) (NN selection) (NN method)) (SBAR (S (VP (TO to) (VP (VB identify) (NP (NP (JJ pathogenic) (NNS factors)) (PP (IN of) (NP (NNP Alzheimer) (NN disease)))) (S (VP (VBG using) (NP (DT the) (ADJP (NN proteomic) (CC and) (JJ clinical)) (NNS data)))))))))) (. .))
(S (NP (DT This) (NN approach)) (VP (VBZ has) (VP (VBN taken) (NP (NP (DT the) (NNS weights)) (PP (IN of) (NP (NN network) (NNS nodes)))) (PP (IN as) (NP (NP (DT the) (NN importance) (NN order)) (PP (IN of) (S (VP (VBG signaling) (NP (JJ protein) (NN expression) (NNS values))))))))) (. .))
(S (PP (IN After) (S (VP (VBG generating) (CC and) (VBG evaluating) (NP (DT the) (NN candidate) (NN subset))))) (, ,) (NP (DT the) (NN method)) (VP (VBZ helps) (S (VP (TO to) (VP (VB select) (NP (NP (DT an) (JJ optimal) (NN subset)) (PP (IN of) (NP (NNS proteins))) (SBAR (WHNP (WDT that)) (S (VP (VBD achieved) (NP (NP (DT an) (NN accuracy)) (ADJP (ADJP (JJR greater)) (PP (IN than) (NP (CD 90) (NN %)))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ superior) (PP (TO to) (NP (NP (JJ traditional) (NN machine) (NN learning) (NNS methods)) (PP (IN for) (NP (JJ clinical) (NNP Alzheimer) (NN disease) (NN diagnosis)))))))))))))))))) (. .))
(S (PP (IN Besides) (S (VP (VP (VBG identifying) (NP (DT a) (JJ proteomic) (NN risk) (NN marker))) (CC and) (VP (ADVP (JJ further)) (NN reinforce) (NP (NP (DT the) (NN link)) (PP (IN between) (NP (NP (JJ metabolic) (NN risk) (NNS factors)) (CC and) (NP (NNP Alzheimer) (NN disease))))))))) (, ,) (NP (DT this) (NN paper)) (ADVP (RB also)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (JJ apidonectin-linked) (NNS pathways)) (VP (VBP are) (NP (DT a) (JJ possible) (JJ therapeutic) (NN drug) (NN target)))))) (. .))
